MBF-118
N/A
Report date: 2023/08/24 09:50:34
NME
Base Information
Drug NameMBF-118
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedibiofarma SL
China Registration ClassN/A
Develop Information
Active CompaniesCrohn’s & Colitis Foundation’s IBD VenturesMedibiofarma SL
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A